蛋白质/抗原/多肽
抗体
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
暂无 | 暂无 | 暂无 | 现货 |
产品介绍
Manufacturer Name | Cat. no | Product Name | Clone | Quantity | Host Species | Specificity | Species Reactivity | Application | Immunogen | Product Type | Status | Recommened Dilution |
DB Biotech | DB 001-0.05 | Anti - Actin | S12-I | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human β-actin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
DB Biotech | DB 002-0.1 | Anti - p53 | S11-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human p53 | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000, ICC - 1:100 - 1:500 |
DB Biotech | DB 002-0.05 | Anti - p53 | S11-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human p53 | monoclonal | primary | |
DB Biotech | DB 003-0.1 | Anti - iNOS | K13-A | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human iNOS sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 003-0.05 | Anti - iNOS | K13-A | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human iNOS sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 004-0.1 | Anti - INTERFERON-γ | K14-B | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human Interferon-γ | monoclonal | primary | WB - 1:5 000, ELISA - 1:10 000 - 1:50 000 |
DB Biotech | DB 004-0.05 | Anti - INTERFERON-γ | K14-B | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human Interferon-γ | monoclonal | primary | WB - 1:5 000, ELISA - 1:10 000 - 1:50 000 |
DB Biotech | DB 005-0.1 | Anti - PKC-α | G13-R | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-α immunoafiinity purified clonal IgGs | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000-1:50 000, ICC - 1:100 - 1:200 |
DB Biotech | DB 005-0.05 | Anti - PKC-α | G13-R | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-α immunoafiinity purified clonal IgGs | monoclonal | primary | |
DB Biotech | DB 006-0.1 | Anti - PKC-βI | A10-F | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βl sequence | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000, ICC - 1:100 - 1:300 |
DB Biotech | DB 006-0.05 | Anti - PKC-βI | A10-F | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βl sequence | monoclonal | primary | |
DB Biotech | DB 007-0.1 | Anti - PKC-βII | N11-S | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βll sequence | monoclonal | primary | WB - 1:10 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:200 - 1:400 |
DB Biotech | DB 007-0.05 | Anti - PKC-βII | N11-S | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βll sequence | monoclonal | primary | |
DB Biotech | DB 008-0.1 | Anti - PKC-γ | A12-H | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-γ sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:5 000 - 1:20 000, ICC - 1:100 - 1:500 |
DB Biotech | DB 008-0.05 | Anti - PKC-γ | A12-H | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-γ sequence | monoclonal | primary | |
DB Biotech | DB 009-0.1 | Anti - PKC-δ | K15-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human PKC-δ sequence | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
DB Biotech | DB 009-0.05 | Anti - PKC-δ | K15-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human PKC-δ sequence | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
DB Biotech | DB 010-0.1 | Anti - PKC-ε | G13-X | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ε sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:50 000, ICC - 1:100 - 1:500 |
DB Biotech | DB 010-0.05 | Anti - PKC-ε | G13-X | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ε sequence | monoclonal | primary | |
DB Biotech | DB 011-0.1 | Anti - PKC-ζ | R14-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ζ sequence | monoclonal | primary | WB - 1:5 00, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
DB Biotech | DB 011-0.05 | Anti - PKC-ζ | R14-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ζ sequence | monoclonal | primary | |
DB Biotech | DB 012-0.1 | Anti - Erk 1,2 | B20-U | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human Erk 2 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
DB Biotech | DB 012-0.05 | Anti - Erk 1,2 | B20-U | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human Erk 2 | monoclonal | primary | |
DB Biotech | DB 013-0.1 | Anti - PHOSPHO-Erk 1,2 | G15-B | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the protein area including conserved pT-E-pY motif of activated Erk 1,2 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
DB Biotech | DB 013-0.05 | Anti - PHOSPHO-Erk 1,2 | G15-B | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the protein area including conserved pT-E-pY motif of activated Erk 1,2 | monoclonal | primary | |
DB Biotech | DB 014-0.1 | Anti - METALLOTHIONEIN | N11-G | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide corresponding to the N-Terminal sequence of human metallothionein (covering isoforms 1A, B,E,F,G,H, I, L, M, Q, S, Y, 2A) | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
DB Biotech | DB 014-0.05 | Anti - METALLOTHIONEIN | N11-G | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide corresponding to the N-Terminal sequence of human metallothionein (covering isoforms 1A, B,E,F,G,H, I, L, M, Q, S, Y, 2A) | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
DB Biotech | DB 017-0.1 | Anti - NEPHRIN | Y17-R | 100 ul | rabbit | human | human,mouse, rat | WB, ELISA, IP | peptide derived from the centre of the fifth Ig-like domain of human nephrin | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
DB Biotech | DB 017-0.05 | Anti - NEPHRIN | Y17-R | 50 ul | rabbit | human | human,mouse, rat | WB, ELISA, IP | peptide derived from the centre of the fifth Ig-like domain of human nephrin | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
DB Biotech | DB 018-0.1 | Anti - CTRP5 | A14-A | 100 ul | rabbit | human | human, mouse | WB, ELISA, IP | peptide close to the amino terminus of human CTRP5 | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
DB Biotech | DB 018-0.05 | Anti - CTRP5 | A14-A | 50 ul | rabbit | human | human, mouse | WB, ELISA, IP | peptide close to the amino terminus of human CTRP5 | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
DB Biotech | DB 019-0.1 | Anti - CTRP7 | K14-S | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide from near the carboxy terminus of human CTRP7 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 019-0.05 | Anti - CTRP7 | K14-S | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide from near the carboxy terminus of human CTRP7 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 022-0.1 | Anti - TRYPSIN | A16-N | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the N terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:4 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 022-0.05 | Anti - TRYPSIN | A16-N | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the N terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:4 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 023-0.1 | Anti - TRYPSIN | G15-J | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the C terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
DB Biotech | DB 023-0.05 | Anti - TRYPSIN | G15-J | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the C terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
DB Biotech | DB 024-0.1 | Anti - NEPHRIN | G17-H | 100 ul | rabbit | human | human, mouse, rat | WB, ELISA, IP | peptide derived from the region near C terminus of first Ig-like domain of human nephrin (between residues Cys53-Cys101) | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
DB Biotech | DB 024-0.05 | Anti - NEPHRIN | G17-H | 50 ul | rabbit | human | human, mouse, rat | WB, ELISA, IP | peptide derived from the region near C terminus of first Ig-like domain of human nephrin (between residues Cys53-Cys101) | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
DB Biotech | DB 033-0.1 | Anti - PRION | T16-R | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived from N-terminal peptide of human prion protein, just before the first octapeptide sequence repeat | monoclonal | primary | WB – 1:1 000, ELISA – 1:10 000 – 1:20 000 |
DB Biotech | DB 033-0.05 | Anti - PRION | T16-R | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived from N-terminal peptide of human prion protein, just before the first octapeptide sequence repeat | monoclonal | primary | WB – 1:1 000, ELISA – 1:10 000 – 1:20 000 |
DB Biotech | DB 080-0.1 | Anti - PRION | V21-V | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the middle of the second α-helical domain of human prion protein | monoclonal | primary | WB – 1:1 000, ELISA – 1:20 000 – 1:50 000 |
DB Biotech | DB 080-0.05 | Anti - PRION | V21-V | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the middle of the second α-helical domain of human prion protein | monoclonal | primary | WB – 1:1 000, ELISA – 1:20 000 – 1:50 000 |
DB Biotech | DB 081-0.1 | Anti - PRION | C16-S | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the C-terminus of third α-helical domain of human prion protein | monoclonal | primary | WB – 1:2 000, ELISA – 1:20,000 – 1:50 000 |
DB Biotech | DB 081-0.05 | Anti - PRION | C16-S | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the C-terminus of third α-helical domain of human prion protein | monoclonal | primary | WB – 1:2 000, ELISA – 1:20,000 – 1:50 000 |
DB Biotech | DB 123-0.1 | Anti - BAX | GL8-R | 100 ul | rabbit | human | human, mouse, rat-tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bax | monoclonal | primary | WB – 1:2 000, ELISA – 1:30 000 – 1:50 000, ICC 1:100 - 1:200 |
DB Biotech | DB 123-0.05 | Anti - BAX | GL8-R | 50 ul | rabbit | human | human, mouse, rat-tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bax | monoclonal | primary | |
DB Biotech | DB 132-0.1 | Anti - Bcl-2 | P22-A | 100 ul | rabbit | human | uman, mouse, rat - tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bcl2 | monoclonal | primary | WB– 1:5 000, ELISA – 1:50,000 – 1:100 000, ICC 1:100 - 1:300 |
DB Biotech | DB 132-0.05 | Anti - Bcl-2 | P22-A | 50 ul | rabbit | human | Human, mouse, rat - tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bcl2 | monoclonal | primary | |
DB Biotech | DB 001-IHC-0.1 | Anti - Actin | S12-I | 100 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 001-0.2 | Anti - Actin | S12-I | 200 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 001-0.5 | Anti - Actin | S12-I | 500 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 001-1 | Anti - Actin | S12-I | 1 ml | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 001-RTU-7 | Anti - Actin | S12-I | 7 ml RTU | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | ready to use | |
DB Biotech | DB 001-RTU-15 | Anti - Actin | S12-I | 15 ml RTU | rabbit | human | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | ready to use | |
DB Biotech | DB 003-IHC-0.1 | Anti - iNOS | K13-A | 100 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 003-0.2 | Anti - iNOS | K13-A | 200 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 003-0.5 | Anti - iNOS | K13-A | 500 ul | rabbit | human | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 | |
DB Biotech | DB 003-1 | Anti - iNOS | K13-A | 1 ml | rabbit | human | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 |
抗体信息由普瑞麦迪(北京)实验室技术有限公司为您提供,如您想了解更多关于抗体报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途